Literature DB >> 16167972

Carriage of CARD15 variants and smoking as risk factors for resective surgery in patients with Crohn's ileal disease.

L Laghi1, S Costa, S Saibeni, P Bianchi, P Omodei, A Carrara, L Spina, E Contessini Avesani, M Vecchi, R De Franchis, A Malesci.   

Abstract

BACKGROUND: It is controversial whether CARD15 variants are truly associated with a more severe form of Crohn's disease. The relative role of CARD15 genotype and smoking in Crohn's disease progression is also debated. AIM: To investigate the association between CARD15 variants and history of resective surgery in patients with Crohn's ileal disease, taking into account smoking as a possible confounding factor.
METHODS: We originally assessed CARD15 genotype in 239 north Italian Crohn's disease patients (mean follow-up: 10.1 +/- 8.1 years). We then focused on 193 patients with proven ileal involvement, 70 of whom (36.3%) carried CARD15-mutated alleles (G908R, R702W, L1007fs).
RESULTS: Carriage of CARD15 variants was positively associated with family history and ileal-only disease and negatively associated with uncomplicated behaviour at maximal follow-up (P < 0.05). Ileal resection was the only variable independently associated with CARD15 variants at multivariate analysis (OR 3.8; 95% CI 1.6-9.2; P = 0.003). Kaplan-Meier analysis showed that ileal resection was favoured both by CARD15 variant-carriage (P = 0.01) and by smoking (P = 0.05), but smoking did not affect progression to surgery in variant carriers (P = 0.31). Thirteen of 14 (93%) patients being resection-free at 15-year follow-up, had CARD15 wild-type genotype (P = 0.01), whereas only seven (50%) had never smoked (P = 1.0).
CONCLUSIONS: In summary, CARD15 variant-associated Crohn's ileitis is virtually committed to stricturing and/or penetrating disease and, eventually, to resective surgery. Smoking accelerates progression to surgery in patients with wild-type CARD15 genotype, but it seems to exert no additional effect in CARD15-variant carriers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167972     DOI: 10.1111/j.1365-2036.2005.02629.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

Review 1.  The impact of smoking in Crohn's disease: no smoke without fire.

Authors:  Marian C Aldhous; J Satsangi
Journal:  Frontline Gastroenterol       Date:  2010-09-23

2.  3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer.

Authors:  Inés Omrane; Amel Mezlini; Olfa Baroudi; Nejla Stambouli; Karim Bougatef; Hager Ayari; Imen Medimegh; Hassen Bouzaienne; Nancy Uhrhammer; Yves-Jean Bignon; Amel Benammar-Elgaaied; Raja Marrakchi
Journal:  Med Oncol       Date:  2014-04-10       Impact factor: 3.064

3.  Prediction of Crohn's disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort.

Authors:  Maneesha Bhullar; Finlay Macrae; Gregor Brown; Margie Smith; Ken Sharpe
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

4.  Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy.

Authors:  Inés Omrane; Imen Medimegh; Olfa Baroudi; Hager Ayari; Walid Bedhiafi; Nejla Stambouli; Marwa Ferchichi; Nadia Kourda; Yves-Jean Bignon; Nancy Uhrhammer; Amel Mezlini; Karim Bougatef; Amel Benammar-Elgaaied
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

Review 5.  The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.

Authors:  M Ellen Kuenzig; Jeff Yim; Stephanie Coward; Bertus Eksteen; Cynthia H Seow; Cheryl Barnabe; Herman W Barkema; Mark S Silverberg; Peter L Lakatos; Paul L Beck; Richard Fedorak; Levinus A Dieleman; Karen Madsen; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan
Journal:  EBioMedicine       Date:  2017-06-16       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.